Your session is about to expire
← Back to Search
Behavioral Intervention
MBCT-Video for Migraine (TEAM-M Trial)
Phase 2
Waitlist Available
Led By Amanda Shallcross, ND, MPH
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age ≥ 18
Currently meets ICHD-3 criteria for migraine using the Structured Diagnostic Interview for Headache
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 8
Awards & highlights
TEAM-M Trial Summary
This study is evaluating whether telephone or video delivery of mindfulness-based cognitive therapy (MBCT) is as effective as in-person delivery.
Eligible Conditions
- Migraine
- Depression
TEAM-M Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTEAM-M Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 8
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 8
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Average Client Satisfaction Questionnaire Score (CSQ-8)
Homework Assignment Completion Rate
Mean Score on MBCT-T/V Adherence & Competence Scales (MBCT-TACS)
+1 moreSide effects data
From 2022 Phase 2 trial • 27 Patients • NCT0499249425%
Flashback
25%
COVID infection
13%
Worsening hyperthyroidism
13%
Worsening mood
13%
Increased severity of migraine
100%
80%
60%
40%
20%
0%
Study treatment Arm
MBCT-T (Mindfulness-Based Cognitive Therapy - Telephone)
MBCT-V (Mindfulness-Based Cognitive Therapy - Video)
TEAM-M Trial Design
2Treatment groups
Experimental Treatment
Group I: MBCT-V (Mindfulness-Based Cognitive Therapy - Video)Experimental Treatment1 Intervention
Mindfulness-based cognitive therapy delivered by Video
Group II: MBCT-T (Mindfulness-Based Cognitive Therapy - Telephone)Experimental Treatment1 Intervention
Mindfulness-based cognitive therapy delivered by Telephone
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MBCT-Video
2021
Completed Phase 2
~30
MBCT-Telephone
2021
Completed Phase 2
~30
Find a Location
Who is running the clinical trial?
NYU Langone HealthLead Sponsor
1,358 Previous Clinical Trials
816,786 Total Patients Enrolled
9 Trials studying Migraine
1,096 Patients Enrolled for Migraine
National Center for Complementary and Integrative Health (NCCIH)NIH
827 Previous Clinical Trials
668,717 Total Patients Enrolled
11 Trials studying Migraine
1,449 Patients Enrolled for Migraine
Amanda Shallcross, ND, MPHPrincipal InvestigatorNYU Langone Health
1 Previous Clinical Trials
20 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What state do they live in?
New York
How old are they?
18 - 65
What site did they apply to?
NYU Langone Health
What portion of applicants met pre-screening criteria?
Met criteria
How responsive is this trial?
Typically responds via
Email
Share this study with friends
Copy Link
Messenger